Clinical Trial Update: Dapagliflozin as Prophylaxis for Glucocorticoid-Induced Hyperglycemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating dapagliflozin (Forxiga) as a preventive treatment for glucocorticoid-induced hyperglycemia; the study is active but not recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glucocorticoid-induced Hyperglycemia
• Hyperglycemia

Drugs mentioned

• Forxiga (dapagliflozin)

Snippet

Sponsor: Lauro Fabián Amador Medina | Conditions: Dapagliflozin (Forxiga), Hyperglycaemia | Phase 2 | Status: ACTIVE_NOT_RECRUITING